Isoma Diagnostics is focused on helping find a cure for one of the deadliest forms of cancer in the world called Glioblastoma Multiforme (GBM).
Our highly accurate diagnostic test can determine which one of the four distinct GBM subtypes each patient has. The technology holds promise to potentially uncover which drugs and therapies are the most effective with each particular subtype, enabling personalized medicine and improving patient outcomes.
18,000 Americans are diagnosed with Glioblastoma each year including Senator John McCain, Ted Kennedy, Beau Biden, and Darren Daulton. The current standard of care for GBM patients hasn’t changed in over twenty years and includes: surgery, radiation, and chemotherapy resulting in a five year survival rate of less than 5%.